Quick Answer
Boundless Bio, Inc. reported Shares Outstanding of 22.41 million shares for fiscal year 2025.
Boundless Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 22.41M | +0.5% |
| 2024 | 22.30M | +1786759.0% |
| 2023 | 1,248 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 22.39M | +0.6% | +0.0% |
| June 30, 2025 | 22.39M | +0.6% | +0.4% |
| March 31, 2025 | 22.30M | +1666.1% | +0.0% |
| December 31, 2024 | 22.30M | +1688.3% | +0.2% |
| September 30, 2024 | 22.25M | — | +0.0% |
| June 30, 2024 | 22.25M | — | +1662.5% |
| March 31, 2024 | 1.26M | — | +1.3% |
| December 31, 2023 | 1.25M | — | — |
- Boundless Bio, Inc. showed an increase of +0.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Boundless Bio, Inc.’s shares outstanding has grown by 1795332.7% (from 1.2 thousand shares to 22.41 million shares).
- The most recent figure is from Boundless Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: